MPH Health Care AG/€93M1
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About MPH Health Care AG
MPH Health Care AG, established in 2008 and headquartered in Berlin, Germany, is an investment holding company focusing on the acquisition, development, and sale of companies within the healthcare sector, particularly in areas such as chronic diseases, medical aesthetic treatments, and healthcare digitalization. Its portfolio includes M1 Kliniken AG, specializing in aesthetic and plastic medical services; HAEMATO AG, a pharmaceutical company concentrating on off-patent and patent-protected drugs; and CR Capital AG, involved in real estate development. MPH Health Care AG's strategic approach emphasizes long-term value creation through active development of its investments, aiming to provide cost-effective services and products of high quality.
- Ticker
- €93M1
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 2
- Headquarters
- Berlin, Germany
- Website
- www.mph-ag.de
93M1 Metrics
BasicAdvanced
€127M
2.64
€11.31
1.10
€5.00
16.72%
Price and volume
Market cap
€127M
Beta
1.1
52-week high
€30.80
52-week low
€17.15
Average daily volume
2K
Dividend rate
€5.00
Financial strength
Current ratio
0.199
Quick ratio
0.183
Long term debt to equity
0
Total debt to equity
0.062
Dividend payout ratio (TTM)
10.61%
Interest coverage (TTM)
87.04%
Profitability
EBITDA (TTM)
49.299
Gross margin (TTM)
100.00%
Net profit margin (TTM)
95.64%
Operating margin (TTM)
97.25%
Effective tax rate (TTM)
1.81%
Revenue per employee (TTM)
€25,320,000
Management effectiveness
Return on assets (TTM)
12.68%
Return on equity (TTM)
21.36%
Valuation
Price to earnings (TTM)
2.643
Price to revenue (TTM)
2.528
Price to book
0.51
Price to tangible book (TTM)
0.51
Price to free cash flow (TTM)
34.026
Free cash flow yield (TTM)
2.94%
Free cash flow per share (TTM)
0.879
Dividend yield (TTM)
16.72%
Forward dividend yield
16.72%
Growth
Revenue change (TTM)
-478.71%
Earnings per share change (TTM)
-142.03%
3-year revenue growth (CAGR)
18.13%
10-year revenue growth (CAGR)
-10.65%
3-year earnings per share growth (CAGR)
-0.86%
10-year earnings per share growth (CAGR)
-7.02%
10-year dividend per share growth (CAGR)
15.34%
93M1 Financial Performance
Revenues and expenses
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.